Hazard characterisation of chemicals in food and diet. dose response, mechanisms and extrapolation issues.
暂无分享,去创建一个
A G Renwick | E Dybing | J Schlatter | J. Schlatter | A. Tritscher | M. Younes | J. Groten | P. Steinberg | E. Dybing | A. Renwick | J. Kleiner | R. Walker | J. Doe | R Walker | J Kleiner | P Steinberg | J Groten | M Younes | A Tritscher | J O'Brien | J Doe | J. O'Brien
[1] J. Caldwell,et al. The current status of attempts to predict species differences in drug metabolism. , 1981, Drug metabolism reviews.
[2] K. Soper,et al. The effects of diet, overfeeding and moderate dietary restriction on Sprague-Dawley rat survival, disease and toxicology. , 1997, The Journal of nutrition.
[3] B. Henderson,et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma , 1992, The Lancet.
[4] J. Groten,et al. Changes in the Nasal Epithelium of Rats Exposed by Inhalation to Mixtures of Formaldehyde, Acetaldehyde, and Acrolein , 1996 .
[5] W. Dekant,et al. Bioactivation of nephrotoxins and renal carcinogens by glutathione S-conjugate formation. , 1993, Toxicology letters.
[6] F. Lu,et al. Acceptable daily intake: inception, evolution, and application. , 1988, Regulatory toxicology and pharmacology : RTP.
[7] J. Swenberg,et al. Biochemical Mechanisms and Pathobiology of α2u-Globulin Nephropathy , 1990 .
[8] L. Bernstein,et al. Interspecies extrapolation in carcinogenesis: prediction between rats and mice. , 1989, Environmental health perspectives.
[9] J. Schenkman,et al. Physiological and pathophysiological alterations in rat hepatic cytochrome P-450. , 1989, Drug metabolism reviews.
[10] Eric D. Schoen,et al. Subacute Toxicity of a Mixture of Nine Chemicals in Rats: Detecting Interactive Effects with a Fractionated Two-Level Factorial Design , 1997 .
[11] G. Williamson,et al. Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism. , 1997, Carcinogenesis.
[12] A. Tischler,et al. Low digestible carbohydrates (polyols and lactose): significance of adrenal medullary proliferative lesions in the rat. , 1996, Regulatory toxicology and pharmacology : RTP.
[13] R. Ings,et al. Interspecies scaling and comparisons in drug development and toxicokinetics. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.
[14] C T De Rosa,et al. Estimation of toxicity of chemical mixtures through modeling of chemical interactions. , 1998, Environmental health perspectives.
[15] W. Dekant,et al. Glutathione-dependent toxicity. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.
[16] L. Lave. Risk Assessment and Management , 2013, Advances in Risk Analysis.
[17] Scientific evaluation of the data-derived safety factors for the acceptable daily intake. Case study: diethylhexylphthalate. , 1993, Food additives and contaminants.
[18] M. Ellis,et al. The role of glutathione conjugation in the development of kidney tumours in rats exposed to trichloroethylene. , 1997, Chemico-biological interactions.
[19] L B Ellwein,et al. The health risks of saccharin revisited. , 1990, Critical reviews in toxicology.
[20] B. P. Mcnamara,et al. Concepts in health evaluation of commercial and industrial chemicals , 1975 .
[21] C. S. Weil,et al. Safety Evaluation of Chemicals, Relationship between Short-and Long-Term Feeding Studies in Designing an Effective Toxicity Test , 1963 .
[22] P. Hepburn,et al. Safety evaluation of phytosterol esters. Part 2. Subchronic 90-day oral toxicity study on phytosterol esters--a novel functional food. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[23] T. Onodera,et al. Antithyroid effects of propylthiouracil and sulfamonomethoxine in rats and monkeys. , 1986, Toxicology and applied pharmacology.
[24] A. Hartwig,et al. Cobalt(II) inhibits the incision and the polymerization step of nucleotide excision repair in human fibroblasts. , 1997, Mutation research.
[25] L. A. Gallenberg,et al. Transfer of persistent chemicals in milk. , 1989, Drug metabolism reviews.
[26] S. Cohen,et al. Rodent bladder tumors do not always predict for humans. , 1995, Cancer letters.
[27] F. Kadlubar,et al. Aromatic amine acetyltransferase as a marker for colorectal cancer: Environmental and demographic associations , 1990, International journal of cancer.
[28] A Poland,et al. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. , 1982, Annual review of pharmacology and toxicology.
[29] W. Calder,et al. Body Size, Physiological Time, and Longevity of Homeothermic Animals , 1981, The Quarterly Review of Biology.
[30] A G Renwick,et al. An analysis of the possibility for health implications of joint actions and interactions between food additives. , 2000, Regulatory toxicology and pharmacology : RTP.
[31] D. Gaylor,et al. Journal Abstracts , 1979, Journal of environmental pathology and toxicology.
[32] C. Paraskeva,et al. The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines. , 1995, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[33] R. Hughes,et al. Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. , 2001, Carcinogenesis.
[34] F. Kadlubar,et al. Role of aromatic amine acetyltransferase in human colorectal cancer. , 1986, Archives of surgery.
[35] I. Rowland,et al. Lactobacillus- and bifidobacterium-mediated antigenotoxicity in the colon of rats. , 1996, Nutrition and cancer.
[36] M. Pieters,et al. Evaluation of the uncertainty factor for subchronic-to-chronic extrapolation: statistical analysis of toxicity data. , 1998, Regulatory toxicology and pharmacology : RTP.
[37] A G Renwick,et al. Human variability and noncancer risk assessment--an analysis of the default uncertainty factor. , 1998, Regulatory toxicology and pharmacology : RTP.
[38] I. Munro,et al. Alternative approaches to the safety assessment of macronutrient substitutes. , 1996, Regulatory toxicology and pharmacology : RTP.
[39] R. Glashan,et al. ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCER , 1982, The Lancet.
[40] C. Gennings,et al. Economical designs for detecting and characterizing departure from additivity in mixtures of many chemicals. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[41] S. Safe,et al. Environmental and dietary estrogens and human health: is there a problem? , 1995, Environmental health perspectives.
[42] H. Til,et al. Subchronic oral toxicity study with regular and enzymatically depolymerized sodium carboxymethylcellulose in rats. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[43] A. Hartwig,et al. Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts. , 1997, Carcinogenesis.
[44] A. Dahl,et al. Nasal cavity enzymes involved in xenobiotic metabolism: effects on the toxicity of inhalants. , 1991, Critical reviews in toxicology.
[45] J. Miller,et al. THE COMPARATIVE CARCINOGENICITIES OF 2-ACETYLAMINOFLUORENE AND ITS N-HYDROXY METABOLITE IN MICE, HAMSTERS, AND GUINEA PIGS. , 1964, Cancer research.
[46] M. Fromm,et al. P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. , 2000, International journal of clinical pharmacology and therapeutics.
[47] J. Tuomisto,et al. Physicochemical differences in the AH receptors of the most TCDD-susceptible and the most TCDD-resistant rat strains. , 1999, Toxicology and applied pharmacology.
[48] T. Kensler,et al. Chemoprotection by Organosulfur Inducers of Phase 2 Enzymes: Dithiolethiones and Dithiins , 2000, Drug metabolism and drug interactions.
[49] U. Thorgeirsson,et al. Tumor incidence in a chemical carcinogenesis study of nonhuman primates. , 1994, Regulatory toxicology and pharmacology : RTP.
[50] J M Ward,et al. Receptor and Nonreceptor-Mediated Organ-Specific Toxicity of Di(2-ethylhexyl)phthalate (DEHP) in Peroxisome Proliferator-Activated Receptorα-Null Mice , 1998, Toxicologic pathology.
[51] M. Kelly,et al. Lack of carcinogenic activity and metabolic fate of fluorenylacetamides in monkeys. , 1966, Journal of the National Cancer Institute.
[52] M. Pirmohamed,et al. Metabolic activation in drug allergies. , 2001, Toxicology.
[53] Safe,et al. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. , 1998, Environmental health perspectives.
[54] Hypnotics and sedatives , 1986 .
[55] F. Guarner,et al. Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat , 2001, American Journal of Gastroenterology.
[56] J. Kolars,et al. First-pass metabolism of cyclosporin by the gut , 1991, The Lancet.
[57] E. Schoen. Statistical designs in combination toxicology: a matter of choice. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[58] D. Gaylor,et al. Relative potency of chemical carcinogens in rodents. , 1986, Risk analysis : an official publication of the Society for Risk Analysis.
[59] A. Hartwig,et al. S9/L3 - Carcinogenicity of metal compounds , 1998 .
[60] J A Miller,et al. Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. , 1970, Cancer research.
[61] M Balls,et al. Methods of in vitro toxicology. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[62] C. I. Bliss. THE TOXICITY OF POISONS APPLIED JOINTLY1 , 1939 .
[63] B. Oser. The rat as a model for human toxicological evaluation. , 1981, Journal of toxicology and environmental health.
[64] E. Calabrese,et al. Can the concept of hormesis Be generalized to carcinogenesis? , 1998, Regulatory toxicology and pharmacology : RTP.
[65] B B Brodie,et al. Possible mechanism of liver necrosis caused by aromatic organic compounds. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[66] A G Renwick,et al. Safety factors and establishment of acceptable daily intakes. , 1991, Food additives and contaminants.
[67] W. Mertz,et al. Risk assessment of essential trace elements: new approaches to setting recommended dietary allowances and safety limits. , 2009, Nutrition reviews.
[68] Sac-fry Stages,et al. OECD GUIDELINE FOR TESTING OF CHEMICALS , 2002 .
[69] B D Beck,et al. Does the animal-to-human uncertainty factor incorporate interspecies differences in surface area? , 1992, Regulatory toxicology and pharmacology : RTP.
[70] K. Ilett,et al. Acetylation phenotype in colorectal carcinoma. , 1987, Cancer research.
[71] A T Eldefrawi,et al. Receptors for γ‐aminobutyric acid and voltage‐dependent chloride channels as targets for drugs and toxicants 1 , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[72] D G Hattan,et al. FDA's priority-based assessment of food additives. III. Specific toxicity parameters. , 1985, Regulatory toxicology and pharmacology : RTP.
[73] C. Schlatter,et al. The Effect of Pregnancy on the Pharmacokinetics of Caffeine , 1981 .
[74] A. Huggett,et al. An integrated in vivo and in vitro strategy to improve food safety evaluation , 1996 .
[75] J. Radomski. The primary aromatic amines: their biological properties and structure-activity relationships. , 1979, Annual review of pharmacology and toxicology.
[76] R. Bronson,et al. Effects of caloric restriction or augmentation in adult rats: Longevity and lesion biomarkers of aging , 1998, Aging.
[77] E. Dybing,et al. Situations with enhanced chemical risks due to toxicokinetic and toxicodynamic factors. , 1999, Regulatory toxicology and pharmacology : RTP.
[78] J. Hook,et al. Toxicology of the Kidney , 1992 .
[79] L. Valcovic,et al. Hazard evaluation of chemicals that cause accumulation of alpha 2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats. , 1993, Environmental health perspectives.
[80] G. Corcoran,et al. The role of the nucleus and other compartments in toxic cell death produced by alkylating hepatotoxicants. , 1992, Toxicology and applied pharmacology.
[81] K. Dalton. Toxicity of vitamins. , 1986 .
[82] J. French,et al. Roles for insulin-like growth factor-1 in mediating the anti-carcinogenic effects of caloric restriction. , 1999, The journal of nutrition, health & aging.
[83] I. Dreosti. Nutrition, Cancer, and Aging , 1998, Annals of the New York Academy of Sciences.
[84] F. Lu,et al. Safety assessments of chemicals with thresholded effects. , 1985, Regulatory toxicology and pharmacology : RTP.
[85] A. Renwick. Data-derived safety factors for the evaluation of food additives and environmental contaminants. , 1993, Food additives and contaminants.
[86] E. Gallagher,et al. Mechanisms of aflatoxin carcinogenesis. , 1994, Annual review of pharmacology and toxicology.
[87] J. Swenberg. Bioassay design and MTD setting: old methods and new approaches. , 1995, Regulatory toxicology and pharmacology : RTP.
[88] C J Portier,et al. Effects of glutathione transferase theta polymorphism on the risk estimates of dichloromethane to humans. , 1999, Toxicology and applied pharmacology.
[89] C. Powell,et al. The dose-dependent effect of BHT (butylated hydroxytoluene) on vitamin K-dependent blood coagulation in rats. , 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[90] M M Mumtaz,et al. A Weight-of-Evidence Approach for Assessing Interactions in Chemical Mixtures , 1992, Toxicology and industrial health.
[91] Roeters Fj. Perspectives in carbohydrate toxicology with special reference to carcinogenicity. , 1984 .
[92] E. Poulsen. Case study: erythrosine. , 1993, Food additives and contaminants.
[93] M. W. Anders. Bioactivation of foreign compounds , 1985 .
[94] Rudolfs K. Zalups,et al. Molecular biology and toxicology of metals , 2000 .
[95] M L Dourson,et al. Regulatory history and experimental support of uncertainty (safety) factors. , 1983, Regulatory toxicology and pharmacology : RTP.
[96] M. Tomita,et al. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. , 1997, Carcinogenesis.
[97] R. Hayes,et al. N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. , 1993, Carcinogenesis.
[98] F. Roe,et al. Enzootic and Epizootic Adrenal Medullary Proliferative Disease of Rats: Influence of Dietary Factors which Affect Calcium Absorption , 1985, Human toxicology.
[99] Thomson,et al. Review article: olestra and its gastrointestinal safety , 1998, Alimentary pharmacology & therapeutics.
[100] M. R. Boyd,et al. Biochemical mechanisms in chemical-induced lung injury: roles of metabolic activation. , 1980, Critical reviews in toxicology.
[101] F. Roe. The Leon Golberg Memorial Lecture. Recent advances in toxicology relevant to carcinogenesis: seven cameos. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[102] W. H. Farland,et al. Workshop report on EPA (Environmental Protection Agency) guidelines for carcinogen risk assessment. Held in Virginia Beach, Virginia on January 11-13, 1989 , 1989 .
[103] A. Monro. The paradoxical lack of interspecies correlation between plasma concentrations and chemical carcinogenicity. , 1993, Regulatory toxicology and pharmacology : RTP.
[104] R K Jain,et al. Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.
[105] J N Hathcock,et al. Safety limits for nutrient intakes: concepts and data requirements. , 2009, Nutrition reviews.
[106] I. Rowland,et al. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. , 1998, Carcinogenesis.
[107] John P. Groten,et al. Sensory irritation to mixtures of formaldehyde, acrolein, and acetaldehyde in rats , 1996, Archives of Toxicology.
[108] C. Rao,et al. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. , 1997, Carcinogenesis.
[109] D G Hoel,et al. Fundamental carcinogenic processes and their implications for low dose risk assessment. , 1976, Cancer research.
[110] J. Groten,et al. Toxicological evaluation and risk assessment of chemical mixtures. , 1998, Critical reviews in toxicology.
[111] S. Safe,et al. Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. , 1986, Annual review of pharmacology and toxicology.
[112] J. Groopman,et al. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. , 1987, Cancer research.
[113] J. Caldwell. Chapter 5 – Comparative Aspects of Detoxication in Mammals , 1980 .
[114] H. Sies,et al. Oxidative stress: oxidants and antioxidants , 1997, Experimental physiology.
[115] W. Vogel. The Effect of Stress on Toxicological Investigations , 1993, Human & experimental toxicology.
[116] R Truhaut,et al. The concept of the acceptable daily intake: an historical review. , 1991, Food additives and contaminants.
[117] M. Brodie,et al. Drug metabolism in liver disease. , 1989, Pharmacology & therapeutics.
[118] W. Slob,et al. Mathematical modelling and quantitative methods. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[119] I W Davidson,et al. Biological basis for extrapolation across mammalian species. , 1986, Regulatory toxicology and pharmacology : RTP.
[120] J. Gustafsson,et al. Sex steroid induced changes in hepatic enzymes. , 1983, Annual review of physiology.
[121] Linda S. Birnbaum,et al. Consultation on assessment of the health risk of dioxins; re-evaluation of the tolerable daily intake (TDI): executive summary. , 2000, Food additives and contaminants.
[122] A. Conney,et al. Regulation of drug metabolism in man by environmental chemicals and diet. , 1977, Federation proceedings.
[123] William B. Jakoby,et al. Enzymatic basis of detoxication , 1980 .
[124] W Slob,et al. Assessment factors for human health risk assessment: a discussion paper. , 1999, Critical reviews in toxicology.
[125] A. Hartwig,et al. Disturbance of DNA damage recognition after UV-irradiation by nickel(II) and cadmium(II) in mammalian cells. , 1998, Carcinogenesis.
[126] Mark D. Hoover,et al. Disposition of polycyclic aromatic hydrocarbons in the respiratory tract of the beagle dog. I. The alveolar region. , 1993, Toxicology and applied pharmacology.
[127] K. Herrold. Aflatoxin induced lesions in Syrian hamsters. , 1969, British Journal of Cancer.
[128] H. Wolf,et al. N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark , 1979, Environmental health perspectives.
[129] M A Butler,et al. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[130] J W Bridges,et al. Hazard identification by methods of animal-based toxicology. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[131] W. Slob,et al. A Probabilistic Approach for Deriving Acceptable Human Intake Limits and Human Health Risks from Toxicological Studies: General Framework , 1998 .
[132] B. Trump,et al. Calcium‐mediated cell injury and cell death , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[133] R. Mcclain. Mechanistic considerations for the relevance of animal data on thyroid neoplasia to human risk assessment. , 1995, Mutation research.
[134] S. Cohen,et al. Role of urinary physiology and chemistry in bladder carcinogenesis. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[135] H. Kay. Environmental Health Criteria , 1980 .
[136] R. Truhaut. Potential Carcinogenic Hazards from Drugs , 1967, UICC Monograph Series.
[137] S. Anttila,et al. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review. , 1995, Gene.
[138] D A Jonas,et al. The safety assessment of novel foods. Guidelines prepared by ILSI Europe Novel Food Task Force. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[139] J. Erdman,et al. Phytic acid in health and disease. , 1995, Critical reviews in food science and nutrition.
[140] Wr. Hobbs,et al. Hypnotics and sedatives; ethanol , 1996 .
[141] J. Mordenti,et al. Man versus beast: pharmacokinetic scaling in mammals. , 1986, Journal of pharmaceutical sciences.
[142] D. Umbenhauer,et al. Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[143] S. Wrighton,et al. The human hepatic cytochromes P450 involved in drug metabolism. , 1992, Critical reviews in toxicology.
[144] P. Harper,et al. Molecular biology of the aromatic hydrocarbon (dioxin) receptor. , 1994, Trends in pharmacological sciences.
[145] M. Abdel‐Rahman,et al. Evaluation of the use of uncertainty factors in deriving RfDs for some chlorinated compounds. , 1995, Journal of toxicology and environmental health.
[146] H M Bolt,et al. Experimental designs and risk assessment in combination toxicology: panel discussion. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[147] E. Schoen,et al. Statistically designed experiments in a tiered approach to screen mixtures of Fusarium mycotoxins for possible interactions. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[148] D. Hicks,et al. Apoptosis in colorectal tumour cells: Induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate , 1995, International journal of cancer.
[149] P. Copestake. Information sectionThe acceptable daily intake , 1989 .
[150] E. Kriek,et al. On the mechanism of action of carcinogenic aromatic amines. I. Binding of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene to rat-liver nucleic acids in vivo. , 1969, Chemico-biological interactions.
[151] M. Blaut,et al. Effects of inulin on faecal bifidobacteria in human subjects , 1999, British Journal of Nutrition.
[152] V. Feron,et al. Toxicity of mixtures of nephrotoxicants with similar or dissimilar mode of action. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[153] J I Goodman,et al. Principles underlying dose selection for, and extrapolation from, the carcinogen bioassay: dose influences mechanism. , 1995, Regulatory toxicology and pharmacology : RTP.
[154] R. Henderson,et al. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. , 1995, Carcinogenesis.
[155] Wout Slob,et al. Thresholds in Toxicology and Risk Assessment , 1999 .
[156] D. Shen,et al. Oral first‐pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A‐mediated metabolism , 1996, Clinical pharmacology and therapeutics.
[157] G Würtzen,et al. Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[158] Gunnar F. Nordberg,et al. Principles and Methods for the Assessment of Risk from Essential Trace Elements , 2002 .
[159] H Boeing,et al. The contribution of epidemiology. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[160] B. Rumack,et al. Acetaminophen poisoning and toxicity. , 1975, Pediatrics.
[161] J. Haist,et al. INCREASED DIETARY CADMIUM ABSORPTION IN MICE AND HUMAN SUBJECTS WITH IRON DEFICIENCY , 1978 .
[162] Mark S. Boyce,et al. Seasonality, Fasting Endurance, and Body Size in Mammals , 1985, The American Naturalist.
[163] E. Dybing,et al. Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis. Proceedings of a consensus conference. Lyon, France, 3-7 November 1997. , 1999, IARC scientific publications.
[164] L. Shuker,et al. ILSI Europe Workshop on Assessing Health Risks From Environmental Exposure to Chemicals: the Example of Drinking Water. Summary Report. International Life Sciences Institute. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[165] J. Ashby,et al. Safety evaluation of phytosterol esters. Part 1. Assessment of oestrogenicity using a combination of in vivo and in vitro assays. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[166] J. Borzelleca. The safety evaluation of macronutrient substitutes. , 1992, Critical reviews in food science and nutrition.
[167] J. Mordenti,et al. Pharmacokinetic scale-up: accurate prediction of human pharmacokinetic profiles from animal data. , 1985, Journal of pharmaceutical sciences.
[168] B. Krajewska,et al. Acetylation phenotypes and bladder cancer. , 1990, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[169] C. Walker. Species differences in microsomal monooxygenase activity and their relationship to biological half-lives. , 1978, Drug metabolism reviews.
[170] M L Dourson,et al. Evolution of science-based uncertainty factors in noncancer risk assessment. , 1996, Regulatory toxicology and pharmacology : RTP.
[171] F. A. Smith,et al. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.
[172] I. Purchase,et al. Thresholds in chemical carcinogenesis. , 1995, Regulatory toxicology and pharmacology : RTP.
[173] B. Brodie,et al. Species, strain and sex differences in metabolism of hexobarbitone, amidopyrine, antipyrine and aniline , 1958 .
[174] John L. Adgate,et al. Subchronic to chronic exposure extrapolation: Toxicologic evidence for a reduced uncertainty factor , 1995 .
[175] Fumio Matsumura,et al. Toxicology of Insecticides , 1975, Springer US.
[176] W. Flamm,et al. The human relevance of the renal tumor-inducing potential of d-limonene in male rats: implications for risk assessment. , 1991, Regulatory toxicology and pharmacology : RTP.
[177] M. Pike,et al. A carcinogenic potency database of the standardized results of animal bioassays , 1984, Environmental health perspectives.
[178] D G Hoel,et al. Nonlinearity of dose-response functions for carcinogenicity. , 1994, Environmental health perspectives.
[179] A. Hartwig. Carcinogenicity of metal compounds: possible role of DNA repair inhibition. , 1998, Toxicology letters.
[180] A. Vercesi,et al. Mitochondrial Effects of Triarylmethane Dyes , 1999, Journal of bioenergetics and biomembranes.
[181] S. Cohen,et al. Calcium phosphate-containing urinary precipitate in rat urinary bladder carcinogenesis. , 1999, IARC scientific publications.
[182] S. Nelson,et al. The role of metabolic activation in drug toxicity. , 1994, Drug metabolism reviews.